Prospective validation of end of treatment ctDNA-MRD by PhasED-Seq in DLBCL patients from a national trial

May 30, 2025
Location: Room S100a or live stream for virtual attendees
Abstract number: 7000

2:45 – 5:45 p.m. CDT

Oral Presentation

  • Presenter: Steven Wang, MD, PhD (Amsterdam UMC)
  • Session: Oral Abstract Session – Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia